KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Cash & Current Investments (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Cash & Current Investments for 16 consecutive years, with $88.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 14.97% to $88.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $88.9 million, a 14.97% decrease, with the full-year FY2025 number at $88.9 million, down 14.97% from a year prior.
  • Cash & Current Investments was $88.9 million for Q4 2025 at Biolife Solutions, up from $79.0 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $104.6 million in Q4 2024 to a low of $19.1 million in Q1 2023.
  • A 5-year average of $58.3 million and a median of $62.2 million in 2022 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: skyrocketed 1291.64% in 2021, then plummeted 68.73% in 2023.
  • Biolife Solutions' Cash & Current Investments stood at $69.9 million in 2021, then fell by 10.26% to $62.7 million in 2022, then fell by 29.53% to $44.2 million in 2023, then soared by 136.7% to $104.6 million in 2024, then dropped by 14.97% to $88.9 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Cash & Current Investments are $88.9 million (Q4 2025), $79.0 million (Q3 2025), and $81.8 million (Q2 2025).